Candriam S.C.A. Merck & Co., Inc. Transaction History
Candriam S.C.A.
- $16.8 Billion
- Q2 2025
A detailed history of Candriam S.C.A. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 1,654,099 shares of MRK stock, worth $145 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
1,654,099
Previous 2,148,488
23.01%
Holding current value
$145 Million
Previous $193 Million
32.1%
% of portfolio
0.78%
Previous 1.24%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,853Shares Held
1.96BCall Options Held
29.2MPut Options Held
29.9M-
Vanguard Group Inc Valley Forge, PA253MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.4 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.73 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.17 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $222B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...